Category : Search result: Northeast India drugs


Myanmar Records Two Earthquakes in Single Day

Myanmar experienced two significant earthquakes within hours on April 27. The tremors, measuring 5.0 and 4.5 magnitude, were felt in parts of northeastern India. Details inside.

NHPC Commissions First Unit of 2,000 MW Subansiri Project

India's largest hydropower plant, the 2,000 MW Subansiri Lower Hydroelectric Project, has begun operations. The first 250 MW unit was inaugurated, promising to boost clean energy and regional development in the Northeast. Read more.

GLP-1 Drugs Show Benefits Beyond Weight Loss

New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.

India Pharma Targets $500B, Innovation Hub by 2047

India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.

Lack of Drug Inspectors Hampers Action on Spurious Drugs

A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.

Himachal Leads Nation in Substandard Drugs: 49 Fail

Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.

Indian Companies Set for Semaglutide Device Windfall

Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.

Page 2 of 4